North America dominated the Legal Cannabis Market in 2025 with approximately 48.3% of global revenue, anchored by the United States as the world's largest single cannabis market through its expansive network of state-level adult-use and medical programs, and supported by Canada's nationwide adult-use framework that established the first comprehensive national legal cannabis model globally.

The Medical Use segment dominated the Legal Cannabis Market in 2025, reflecting the global head start of medical cannabis programs over recreational frameworks, the well-documented therapeutic demand from patients managing chronic conditions, and the physician-led patient acquisition model that creates consistent, repeat-purchase demand across the more than 55 countries with established medical cannabis frameworks.

The Marijuana segment dominated the Legal Cannabis Market in 2025 with approximately 76.4% of global revenue, driven by its central role across licensed medical cannabis programs, adult-use retail markets in North America, and growing European medical frameworks where marijuana-derived products command significant consumer and patient demand across flower, concentrate, and extract formats.

The progressive global expansion of legal frameworks covering both medical and adult-use cannabis, combined with growing clinical recognition of cannabinoid therapeutic applications, increasing consumer acceptance of cannabis as a mainstream wellness and recreational product, and the ongoing conversion of illicit market consumption into regulated commercial revenue as legal access expands across new geographies.

The Legal Cannabis Market was valued at USD 27.84 billion in 2025.

The Legal Cannabis Market is expected to grow at a CAGR of 23.28% from 2026 to 2035.